glp 1 receptor agonist drugs Table from Glucagon-Like Peptide-1 (GLP-1) Agonists Drug Class Review Research shows GLP-1 receptor agonist

Description

Shift could reflect a changing demand away from oncology toward addressing metabolic disorders GLP1 agonist drugs transformed the weight loss and diabetes landscape in 2023, propelled by robust clinical trial results and a surge in endorsements from celebrities and influencers

doi:10.2967/jnumed.106.038679 80

Sustained Impact Weight loss extended for most individuals, even months after discontinuing

Kickstarting weight loss with medications like Zepbound can also make it easier to adopt the necessary lifestyle changes to reach weight loss goals

Available online: [DOI] [PubMed] [Google Scholar] 37.Goudet P., Murat A., Binquet C., Cardot-Bauters C., Costa A., Ruszniewski P., Niccoli P., Mngaux F., Chabrier G., Borson-Chazot F., et al